about
Preeclampsia, hypoxia, thrombosis, and inflammationCirculating microparticle levels are reduced in patients with ARDS.Task-oriented modular decomposition of biological networks: trigger mechanism in blood coagulation.A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability.The participation of leukocytes in coagulant reactions.Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects.The role of mononuclear cell tissue factor and inflammatory cytokines in patients with chronic thromboembolic pulmonary hypertension.New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban.Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis.Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerationsInhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.Recombinant activated factor VII in cardiac surgery - first, do no harm.Thrombotic risk factors in patients undergoing chemotherapy via peripherally inserted central catheter.Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.Tissue factor in neutrophils: no.PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.Zinc supplementation ameliorates glycoprotein components and oxidative stress changes in the lung of streptozotocin diabetic rats.Stochastic modeling of blood coagulation initiation.Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells.Tissue factor and thrombosis: The clot starts here.
P2860
Q27000388-CEB9B19A-3670-4FCB-8479-52FDEB73F6E3Q33730684-01680BA3-A993-4E2B-A998-18960BD6212DQ33820975-953E9C53-5304-4D73-A3F6-FBC71836B5C5Q33921037-30E35382-2D4A-4DF8-9BA4-577CBD8BB46BQ34893956-81DF9D08-E86E-4F12-942C-025646C91981Q35181738-7137A189-FA31-45D9-ABD9-DD42E511516EQ36639373-11DC4C79-2EC8-4037-AC70-2C4FFE7526D7Q36928024-A617CE7A-C66D-4BA3-9EBA-9942AD23F439Q37004031-418B0EF8-A569-471B-BB40-74C51D91A9EEQ37173216-636158A4-2965-4619-86A6-AF885D46DBBFQ37715189-1A53F348-8143-4A09-80DB-420925791BD2Q40539614-A2AE96B8-35AE-4833-8F82-6B6F36F9F76EQ42236619-FAA65F29-DAA6-4181-9799-3DED7174143BQ42912859-D4C653CE-29D6-43E0-AFF4-BA26B6EC4E16Q45817393-43801C28-F342-497E-9746-CD751D294EFEQ45881934-EDEFF8B0-A38F-4CE8-9DD5-FBACDE6BADA0Q48002959-35891D6E-E673-4C31-B017-242AE44C76C8Q48560473-669F3CB8-EA89-4CDD-A5DE-02D80D6E85D3Q50937465-ACACC9BF-377A-4775-857F-5E75ABB2A1F7Q51283347-F8070B32-D350-42DC-B23C-3384D415438BQ51732019-3C7E2C9B-79B4-4D4E-A97F-22A516C03F22Q52927674-3E5283D7-1337-41A6-84D6-1F49B1FB67EBQ55535116-4961A11F-C21A-443F-86C5-FB38365C007F
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Circulating tissue factor and thrombosis.
@ast
Circulating tissue factor and thrombosis.
@en
Circulating tissue factor and thrombosis.
@nl
type
label
Circulating tissue factor and thrombosis.
@ast
Circulating tissue factor and thrombosis.
@en
Circulating tissue factor and thrombosis.
@nl
prefLabel
Circulating tissue factor and thrombosis.
@ast
Circulating tissue factor and thrombosis.
@en
Circulating tissue factor and thrombosis.
@nl
P1476
Circulating tissue factor and thrombosis.
@en
P2093
P304
P356
10.1097/00062752-200009000-00003
P577
2000-09-01T00:00:00Z